Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel to review Humira, Enbrel biosimilars this week
FDA panel to review Humira, Enbrel biosimilars this week
FDA panel to review Humira, Enbrel biosimilars this week
Submitted by
admin
on July 12, 2016 - 9:22am
Source:
BioPharma Dive
News Tags:
FDA
advisory panels
Humira
Enbrel
biosimilars
ABP-501
Amgen
AbbVie
GP2015
Novartis
Headline:
FDA panel to review Humira, Enbrel biosimilars this week
Do Not Allow Advertisers to Use My Personal information
